MULTIPHASIC EFFECT OF MORPHINE ON THE RELEASE OF SUBSTANCE-P FROM RAT TRIGEMINAL NUCLEUS SLICES

被引:50
作者
SUAREZROCA, H
ABDULLAH, L
ZUNIGA, J
MADISON, S
MAIXNER, W
机构
[1] UNIV N CAROLINA, DENT RES CTR, DEPT PHARMACOL, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, DENT RES CTR, DEPT ENDODONT, CHAPEL HILL, NC 27599 USA
[3] UNIV N CAROLINA, DENT RES CTR, DEPT ANAT & CELL BIOL, CHAPEL HILL, NC 27599 USA
关键词
MORPHINE; OPIOID RECEPTOR; SUBSTANCE-P; TRIGEMINAL NUCLEUS CAUDALIS; NALOXONE; PEPTIDE RELEASE;
D O I
10.1016/0006-8993(92)90050-J
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It is generally accepted that morphine acts presynaptically to inhibit substance P (SP) release from afferent terminals in the trigeminal nucleus. Recent studies, however, provide evidence that opioids produce both inhibitory and excitatory effects on SP release which are concentration-and receptor subtype-dependent. In the present study, we have examined a wide range of morphine concentrations on K+-evoked SP release from rat trigeminal nucleus caudalis slices. Immunoreactive SP was measured in perfusates. Morphine produced multiphasic effects on K+-evoked SP release without affecting basal release. A very low nanomolar concentration (1 nM) suppressed release, higher nanomolar concentrations (100-300 nM) facilitated release, a low micromolar concentration (3-mu-M) suppressed release, and a higher micromolar molar concentration (30-mu-M) facilitated release. These effects were abolished by opioid receptor blockade with naloxone (30 nM). Thus, morphine produces a complex bi-directional modulation of SP release from TNC which is concentration- and possibly receptor subtype-dependent.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 39 条
[1]  
ABDULLAH LH, 1985, THESIS QUEENS U BELF
[2]  
BESSE D, 1990, PROG CLIN BIOL RES, V328, P183
[3]   SUFENTANIL, MORPHINE, MET-ENKEPHALIN, AND KAPPA-AGONIST (U-50,488H) INHIBIT SUBSTANCE-P RELEASE FROM PRIMARY SENSORY NEURONS - A MODEL FOR PRESYNAPTIC SPINAL OPIOID ACTIONS [J].
CHANG, HM ;
BERDE, CB ;
HOLZ, GG ;
STEWARD, GF ;
KREAM, RM .
ANESTHESIOLOGY, 1989, 70 (04) :672-677
[4]   INHIBITOR OF CYCLIC AMP-DEPENDENT PROTEIN-KINASE BLOCKS OPIOID-INDUCED PROLONGATION OF THE ACTION-POTENTIAL OF MOUSE SENSORY GANGLION NEURONS IN DISSOCIATED CELL-CULTURES [J].
CHEN, GG ;
CHALAZONITIS, A ;
SHEN, KF ;
CRAIN, SM .
BRAIN RESEARCH, 1988, 462 (02) :372-377
[5]  
CHEN L, 1990, NEUR ABST, V16, P60
[6]   SELECTIVITY OF LIGAND-BINDING TO OPIOID RECEPTORS IN BRAIN MEMBRANES FROM THE RAT, MONKEY AND GUINEA-PIG [J].
CLARK, MJ ;
CARTER, BD ;
MEDZIHRADSKY, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (03) :343-351
[7]   DISTINCT SUBTYPES OF THE OPIOID RECEPTOR WITH ALLOSTERIC INTERACTIONS IN BRAIN MEMBRANES [J].
DEMOLIOUMASON, CD ;
BARNARD, EA .
JOURNAL OF NEUROCHEMISTRY, 1986, 46 (04) :1118-1128
[8]   EVIDENCE FOR THE NEUROPEPTIDE CHOLECYSTOKININ AS AN ANTAGONIST OF OPIATE ANALGESIA [J].
FARIS, PL ;
KOMISARUK, BR ;
WATKINS, LR ;
MAYER, DJ .
SCIENCE, 1983, 219 (4582) :310-312
[9]   MULTIPLE OPIATE RECEPTOR-SITES ON PRIMARY AFFERENT-FIBERS [J].
FIELDS, HL ;
EMSON, PC ;
LEIGH, BK ;
GILBERT, RFT ;
IVERSEN, LL .
NATURE, 1980, 284 (5754) :351-353
[10]   INDIRECT EVIDENCE FOR PRESYNAPTIC LOCATION OF OPIATE RECEPTORS ON CHEMOSENSITIVE PRIMARY SENSORY NEURONS [J].
GAMSE, R ;
HOLZER, P ;
LEMBECK, F .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1979, 308 (03) :281-285